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1. Introduction 
Despite advances in diagnosis and treatment, the morbidity and mortality of lung cancer 
remains to mount up. The key factor of cancer associated morbidity and mortality is 
principally attributable to the development of metastases. Cancer cells depart their normal 
microenvironment from the primary tumor site through complicated and multistep 
processes disseminate and colonize distant organs [1]. However, the cellular and molecular 
machinery underlying metastasis is relatively poorly understood so far. In order to resist 
cancer dissemination, more effective therapeutic strategies are clearly required. 
Cellular migration and invasion mechanism are commonly thought to be associated with 
Rho family GTPases [2-4], JAK-STAT [5-7], MAPK [8-10], Wnt [11-13], Notch pathway [14-
16]. Recently, epithelial–mesenchymal transition (EMT) programs have become the focus of 
the mechanism of metastasis [1, 17-20]. EMT is an embryologically conserved genetic 
program by which epithelial cells down regulate intercellular tight junctions, loose polarity, 
express mesenchymal markers, and manifest a migratory phenotype [1]. In the EMT 
process, Rho family GTPases [21], JAK-STAT [22], MAPK [23], Wnt [24] and Notch [25] 
pathways may also play an important role. In recent years, emerging studies have 
highlighted the critical role of these pathways and their regulation by microRNAs 
(miRNAs) in cancer invasion and metastasis. 
MiRNAs, short (18-24 nucleotides) non-coding RNAs, are derived from long transcripts pri-
miRNAs and pre-miRNAs [26-30]. By targeting 3’ untranslated regions (3’UTRs) of cognate 
mRNAs, miRNAs post-transcriptionally regulate gene expression and induce translational 
repression [29, 30]. Their specificity is determined by nucleotides 2–8 at the 5′ end, termed the 
miRNA “seed sequence”. To date, 1527 human miRNAs have been identified (Sanger miRBase 
18 http://www.miRbase.org/index. shtml), forming less than 1% of all human genes, 
potentially regulating more than 10% of all protein coding genes [1]. Recently, miRNAs have 
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been discovered to play important roles in the invasion and metastasis of malignant tumors. 
[31-33]. Understanding specific characteristics of miRNAs would probably serve as predictive 
markers and as therapeutic strategies for patients with metastasis.  
In light of these recent discoveries, the present article discusses how invasion and EMT 
pathways are regulated by miRNAs. We have classified invasion programs and key proteins 
involved in EMT according to the signaling pathway showed above and point out validated 
miRNAs regulating their expression and highlight critical knowledge gaps that remain to be 
addressed to enable improved understanding of the molecular mechanisms behind EMT 
and metastasis. A list of experimentally validated miRNAs regulating key proteins involved 
in invasion–metastasis programs or participating in some principal pathways can be found 
in Figure 1.  
 
Figure 1. The experimentally validated miRNAs regulate key proteins involved in invasion–metastasis 
programs or participating in some principal pathways. 
2. Rho family of GTPases 
The Rho family of GTPases, a family of small (~21 kDa) signaling G protein, is a subfamily 
of the Ras superfamily [34]. In mammals, the Rho family is made of 20 members distributed 
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into eight subfamilies: Rho, Rac, Cdc42, Rnd, RhoU/V, RhoBTB, RhoH and RhoD/F. Almost 
all research involves the three most common members of the Rho family: Cdc42, Rac1 and 
RhoA [35]. Over expression of Rho GTPases is associated with reorganization of actin 
cytoskeleton, which plays an important role in cell migration, invasion and metastasis that 
are important aspects of cancer progression [36].  
Emerging studies have indicated that miRNAs participate in the Rho GTPases signaling 
pathway. Among the tested miRNAs, the present articles demonstrated that miR-155, miR-
185, miR-31 and miR-133a are associated with RhoA in cell migration and invasion. MiR-155 
may play an important role in TGF-β-induced EMT and cell migration and invasion by 
targeting RhoA [37]. MiR-185 is a negative regulator of RhoA and Cdc42, and could inhibit 
proliferation and invasion of colorectal cancer cells [38]. The Effects of miR-31 on metastasis 
may be associated with concurrent suppression of integrin alpha 5, radixin, and RhoA 
phenocopies [39]. Chiba and his colleagues reported that RhoA expression is negatively 
regulated by miR-133a in bronchial smooth muscle cells [40].  
Moreover, some studies discussed the regulation of cell migration and invasion by miRNA 
may be attribute to Rho-associated serine-threonine protein kinase (ROCK), one of the best 
characterized downstream effectors of Rho, that is activated when it selectively binds to the 
active GTP-bound form of Rho [41, 42]. As with Rho, ROCK has been implicated in altering 
cell migration and invasion during tumor cell metastasis [43, 44]. Yu and his colleagues 
indicate that downregulation of miR-205 resulted in an increase in Rho-ROCKI activity, 
phosphorylation of the actin severing protein cofilin, and a corresponding diminution of 
filamentous actin [45]. 
A number of articles reported that some miRNAs regulate cell migration and invasion by 
targeting Rac and Cdc42. Recently, microRNA-142-3p, a new regulator of Rac1, suppresses 
the migration and invasion of hepatocellular carcinoma cells [46]. The regulation of cancer 
cell migration by MiR-10b may be attribute to activate Rac by targets Tiam1 [47]. MiR-151 
exerts this function by directly targeting RhoGDIA, a putative metastasis suppressor in 
hepatocellular carcinoma (HCC), thus leading to the activation of Rac1, Cdc42 and Rho 
GTPases [48]. Liu and his colleagues have found that miR-137 may have a tumor suppressor 
function by directly targeting Cdc42 to inhibit the proliferation and invasion activities of 
colorectal cancer cells [49, 50]. MiR-206 may suppress invasion and migration of MDA-MB-
231 cells in vitro partly via regulating actin cytoskeleton remodelling by downregulating 
Cdc42 [51]. MiR-29 activates p53 by targeting p85 alpha and Cdc42 [52]. 
In addition, MiR-21 targets the tumor suppressor Rho B and regulates proliferation, 
invasion positively in colorectal cancer cells [53, 54]. Jiang and his colleagues have indicated 
that miR-138 plays an important role in tongue squamous cell carcinoma cell migration and 
invasion by concurrently targeting Rho C and ROCK2 [36]. Studies on the association of Rho 
with miRNAs highlight the importance of miRNAs in invasion and metastasis of malignant 
tumors. 
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3. JAK-STAT 
The JAK-STAT signaling pathway transmits information from chemical signals outside the 
cell, through the cell membrane, and into gene promoters on the DNA in the cell nucleus, 
which causes DNA transcription and activity in the cell. JAK, short for Janus Kinase, is a 
family of intracellular, nonreceptor tyrosine kinases that transduce cytokine-mediated 
signals via the JAK-STAT pathway. As a key component of the JAK/STAT pathway, Signal 
Transducer and Activator of Transcription, an important transcription factors, is activated 
by JAK [55, 56]. In JAK and STAT family, emerging studies have indicated that JAK2/STAT3 
pathway is well-established regulators of cell migration, and has been implicated in the 
process of tumor cell invasion and metastasis [57].  
Some studies have indicated that miRNAs participate in the JAK-STAT signaling pathway. 
MiR-375 may function as a tumor suppressor to regulate gastric cancer cell proliferation 
potentially by targeting the JAK2 oncogene [58]. MiR-125b suppresses the proliferation and 
migration of osteosarcoma cells through downregulation of STAT3 [59]. Transfection of 
precursor miR-199a-3p into osteosarcoma cell lines significantly decreased cell growth and 
migration. Duan and his colleagues observed decreased mTOR and STAT3 expression in 
miR-199a-3p transfected cells [60]. Yan and his colleagues indicated that miR-20a regulates 
STAT3 at the post-transcriptional level, resulting in inhibition of cell proliferation and 
invasion of pancreatic carcinoma [61].  
4. MAPK pathway 
The Mitogen Activated Protein Kinase (MAPK) pathway is a frequent event in 
tumorigenesis. MAPKs have been implicated in cell migration, proteinase induction, 
apoptosis, and angiogenesis, events that are essential for successful completion of metastasis 
[8]. The presence of at least six MAPK in yeast suggests that there are more in mammals: 
extracellular signal-regulated kinases (ERK1, ERK2), c-Jun N-terminal kinases (JNKs), p38 
isoforms, ERK5, ERK3/4, ERK7/8. In vivo and in vitro studies have confirmed that three 
major subgroups of MAPK including ERK1/2, JNK, and p38, are specifically involved in 
invasion and metastasis [9, 10, 62].  
Mounting studies have indicated that miRNAs participate in the MAPK signaling pathway. 
MiR-143 plays an important role in prostate cancer proliferation, migration and 
chemosensitivity by suppressing KRAS and subsequent inactivation of MAPK pathway [63]. 
MiR-17-5p significantly activates the p38 kinase pathway [64]. Raf kinase inhibitory protein 
suppresses a cascade of metastasis signalling involving LIN28 and let-7 [65]. Zhu and his 
colleagues found that miR-101 targets MAPK phosphatase 1 to regulate the activation of 
MAPKs in macrophages [66]. MiR-146a suppresses tumor growth and progression by 
targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate 
cancer [67]. Liu and his colleagues indicated that miR-21 induces tumor angiogenesis 
through targeting PTEN, leading to activate AKT and ERK1/2 signaling pathways [68,69]. 
EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway 
that targets the ETS2 transcriptional repressor ERF [70].  
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5. Wnt signaling pathway 
Wnt signaling pathway controls tissue polarity and cell movement through the activation of 
RhoA, JNK, and nemo-like kinase (NLK) signaling cascades. The Wnt gene family is a group 
of developmental genes that encode cysteine-rich glycosylated proteins [71]. Aberrant 
activation of Wnt signaling pathway in human cancer leads to more malignant phenotypes, 
such as abnormal tissue polarity, invasion, and metastasis [72].  
A number of studies have indicated that miRNAs participate in the Wnt signaling pathway. 
MiR-200a is a new tumor suppressor that can regulate the activity of the Wnt/β-catenin 
signaling pathway [73]. MiR-371-373 expression is induced by lithium chloride and is 
positively correlated with Wnt/β-catenin-signaling activity in several human cancer cell 
lines [74]. MiR-27 directly targeted and inhibited adenomatous polyposis coli (APC) gene 
expression, and activated Wnt signaling through accumulation of β-catenin [75]. Kapinas 
and his colleagues reported that miR-29 modulates Wnt signaling in human osteoblasts 
through a positive feedback loop [76]. MiR-17-5p plays an important role in breast cancer 
cell invasion and migration by suppressing HBP1 and subsequent activation of Wnt/β-
catenin [77]. Kennell and his colleagues demonstrated that miR-8 family members play an 
evolutionarily conserved role in regulating the Wnt signaling pathway [78].  
6. Notch signaling pathway 
The Notch signaling pathway is a conserved ligand–receptor signaling pathway. Notch 
genes encode single-pass transmembrane proteins that can be activated by interacting with a 
family of its ligands. To date, four Notch receptors have been identified in mammals, 
including human, such as Notch-1-4. It has been well known that Notch signaling plays 
important roles in maintaining the balance involved in cell proliferation, survival, apoptosis, 
and differentiation which affects the development and function of many organs [79]. 
Therefore, dysfunction of Notch prevents differentiation, ultimately guiding 
undifferentiated cells toward malignant transformation. Indeed, many observations suggest 
that alterations in Notch signaling are associated with invasion and metastasis in many 
human cancers [14-16]. 
Mounting studies have indicated that miRNAs participate in the Notch signaling pathway. 
MicroRNA-23b is capable of inducing tolerogenic properties of dendritic cells in vitro 
through the inhibition of the Notch1 and NF-κB signalling pathways [80]. MicroRNA-181 
promotes natural killer (NK) cell development by regulating Notch signaling [81]. MiR-124a 
mediates stroke-induced neurogenesis by targeting the JAG-Notch signaling pathway [82]. 
Pang and his colleagues demonstrated that miR-34a affected cell invasion by regulating 
expression of urokinase plasminogen activator through Notch [83]. MiR-206 targets Notch 3, 
activates apoptosis, and inhibits tumor cell migration and focus formation [84]. MiR-1 
influences cardiac differentiation in Drosophila and regulates Notch signaling [85]. Some 
studies indicated that the ZEB1/miR-200 feedback loop controls Notch signalling in cancer 
cells [86, 87].  
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7. EMT 
Several oncogenic pathways (Rho GTPases, JAK-STAT, MAPK, Wnt and Notch) may induce 
EMT [21-25]. In particular, the association of those pathways with EMT has been shown to 
activate EMT-inducing transcriptional regulators such as the members of the Snail family, 
the zinc finger transcription factors (ZEB), Transforming growth factor beta (TGF-β), Twist 
and Slug.  
Members of the Snail family of transcriptional regulators, namely Snail 1 and Snail 2, have 
emerged as a key regulatory factor of EMT. The zinc finger transcription factors ZEB1 and 
ZEB2 also make a pivotal contribution to this regulation. TGF-β, a major inducer of EMT, 
exists in at least three isoforms called TGF-β1, TGF-β2 and TGF-β3. It cooperates with stem 
cell pathways like Wnt, Ras and Notch to induce EMT [88, 89]. Twist, a basic helix-loop-
helix transcription factor, exists in at least two isoforms called Twist 1 and Twist 2. Twist 
proteins promote EMT by turning-down the expression of epithelial specific proteins, such 
as the E-cadherin and by up-regulating the expression of mesenchymal markers such as the 
N-cadherin, the vimentin and the smooth-muscle actin [90]. Slug, a zinc finger transcription 
factor, whose product belongs to the Snail family of developmental regulatory proteins, is 
transcriptional repressors of E-cadherin and induces EMT [1].  
Emerging studies have indicated that miRNAs participate in the EMT. The miR-106b-25 
cluster targets Smad7, activates TGF-β signaling, and induces EMT in human breast cancer 
[91]. MiR-27 promoted EMT by activating the Wnt pathway [92]. MiR-221/222 targeting of 
trichorhinophalangeal 1 (TRPS1) promotes EMT in breast cancer [93]. MiR-194 inhibits EMT 
of endometrial cancer cells by targeting oncogene BMI-1 [94]. Let-7d negatively modulates 
EMT expression and also plays a role in regulating chemo-resistant ability in oral cancer 
[95]. MiR-200b and miR-15b regulate chemotherapy-induced EMT in human tongue cancer 
cells by targeting BMI-1 [96]. Kumarswamy and his colleagues found that miR-30a targets 
Snai1, inhibits invasion and metastasis, and is downregulated in non-small cell lung cancer 
(NSCLC) [97]. Vetter and his colleagues indicated that miR-661 expression in Snail 1-
induced EMT contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 
messengers [98]. Some studies indicated that the miR-200 family and miR-205 regulate EMT 
by targeting ZEB1 and SIP1 [99, 100].  
8. MicroRNAs in invasion and metastasis in lung cancer  
Lung cancer is the leading cause of death among the malignant tumors worldwide, and the 
incidence of lung cancer is increasing. Tumor invasion and metastasis are the critical steps in 
determining the aggressive phenotype of human cancers. Mortality of tumor patients results 
mainly from cancer cells spreading to distant organs. In order to resist cancer dissemination, 
more effective therapeutic strategies are clearly required. However, the cellular and 
molecular machinery, underlying invasion and metastasis by miRNA in lung cancer, is 
relatively poorly understood. In light of these recent discoveries, we have classified the 
experimentally validated miRNAs regulating the invasion and metastasis of lung cancer and 
showed in Figure 2.  
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Figure 2. The experimentally validated miRNAs regulate the invasion and metastasis in lung cancer. 
In light of these recent discoveries, the present article indicated that miRNAs participate in 
invasion and metastasis in lung cancer. Zhu and his colleagues indicated that MTA1 
functions in regulating the invasive phenotype of lung cancer cells and this regulation may 
be through altered miRNA expression, such as miR-125b, miR-210, miR-103, miR-194 and 
miR-500 [101]. Hu and his colleagues reported that MiR-193b modulated proliferation, 
migration, and invasion of NSCLC [102]. A p53/miR-34 axis has been found that it regulates 
Snail1-dependent cancer cell EMT [103]. MiR-378 is associated with NSCLC brain metastasis 
by promoting cell migration, invasion and tumor angiogenesis [104]. MiR-30a targets Snai1, 
inhibits invasion and metastasis, and is downregulated in NSCLC [105]. Expression level of 
miR-206 was inversely correlated with metastatic potential of lung cancer [106]. Roybal and 
his colleagues demonstrated that miR-200 Inhibits lung adenocarcinoma cell invasion and 
metastasis by targeting Flt1 [107]. Loss of miR-200c expression induces an aggressive, 
invasive, and chemoresistant phenotype in NSCLC [108]. In our previous studies, we found 
that hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in NSCLC and have inverse 
effects on invasion and migration of lung cancer cells [109]. Zhang and his colleagues 
reported that miR-21 post-transcriptionally downregulates the expression of tumor 
suppressor PTEN and stimulates growth and invasion in NSCLC [110]. Crawford and his 
colleagues indicated that MiR-126 alters lung cancer cell phenotype by inhibiting adhesion, 
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migration, and invasion and the effects on invasion may be partially mediated through Crk 
regulation [111]. The deep mechanisms of miRNAs in invasion and metastasis which 
contribute to lung cancer are worthy of further investigation. 
9. Conclusion and future perspective 
Despite recent advances in diagnosis and treatment, lung cancer remains a leading cause of 
death among the malignant tumors worldwide, and the incidence of lung cancer is 
increasing. Even so, no improvement in prognosis has been observed if the patient presents 
with metastases at diagnosis. A better understanding of the mechanism of tumor cell 
invasion is critical for the development of more effective treatments for metastatic cancer. In 
recent years, emerging studies have attested to the association between miRNAs and the 
mechanism in critical processes during cancer dissemination, and we have summarized 
many of these in the present manuscript. Here, we have condensed much of this early work, 
and highlight key deregulated miRNAs targeting molecules involved in Rho family 
GTPases, JAK-STAT, MAPK, Wnt, Notch pathway and transcriptional control of EMT. In 
the future, a more complete dissection of the pathways controlled by miRNAs may offer 
new insights on metastasis, and highlight promising areas for the development of novel 
anti-cancer therapies.  
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